Dehydroepiandrosterone (DHEA) in relation to breast cancer
- 6 December 2024
- book chapter
- Published by Elsevier
- Vol. 129, 61-97
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Glucocorticoids Increase Interleukin–6–Dependent Gene Induction by Interfering With the Expression of the Suppressor of Cytokine Signaling 3 Feedback InhibitorHepatology, 2011
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With HysterectomyJAMA, 2006
- Relationships Among Plasma Dehydroepiandrosterone Sulfate and CortisolLevels, Symptoms of Dissociation, and Objective Performance in Humans Exposedto Acute StressArchives of General Psychiatry, 2004
- Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal WomenJAMA, 2003
- Pathobiologic Findings in DCIS of the Breast: Morphologic Features, Angiogenesis, HER-2/neu and Hormone ReceptorsExperimental and Molecular Pathology, 2001
- A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment GuidelinesRegulatory Toxicology and Pharmacology, 1999
- Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesisInternational Journal of Cancer, 1995
- Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cellsEuropean Journal of Immunology, 1990
- Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4European Journal of Immunology, 1989